EXACT Therapeutics AS (FRA:56F)

Germany flag Germany · Delayed Price · Currency is EUR
0.0995
-0.0015 (-1.49%)
Last updated: Dec 4, 2025, 9:11 AM CET
-80.30%
Market Cap 8.33M
Revenue (ttm) n/a
Net Income (ttm) -6.08M
Shares Out n/a
EPS (ttm) -0.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 0.0995
Previous Close 0.1010
Day's Range 0.0995 - 0.0995
52-Week Range 0.0685 - 0.5050
Beta n/a
RSI 47.96
Earnings Date Dec 25, 2025

About EXACT Therapeutics AS

EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology and brain diseases. The company’s ACT platform is under Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for pancreatic, glioblastoma, an... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2012
Employees 12
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 56F
Full Company Profile

Financial Performance

Financial numbers in NOK Financial Statements

News

There is no news available yet.